Evofem Biosciences (EVFM) Misses Q4 EPS by 3c

Evofem Biosciences (OTC: EVFM) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $7.1 million.

For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight